Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.
PolandAll drugs from this manufacturer
-
The medicine is used to treat children (from 1 year of age), adolescents, and young adults (up to 21 years of age) suffering from acute lymphoblastic leukemia (ALL), in cases where previous therapies have not been effective or have ceased to work.
Dosage form: solution for infusion, concentrate
Active substance Dosage clofarabine 20,0 mg ATC: L01BB06
-
The medicine is used in adults for the treatment of stable angina pectoris (chest pain) and in the treatment of chronic heart failure when the resting heart rate is elevated.
Dosage form: tablets, film-coated
Active substance Dosage ivabradine 2.5 mg ATC: C01EB17
-
The medicine is used in adults for the symptomatic treatment of stable angina pectoris (at a heart rate of 70 beats per minute or higher) and for the treatment of chronic heart failure (at a heart rate of 75 beats per minute or higher).
Dosage form: tablets, film-coated
Active substance Dosage ivabradine 5 mg ATC: C01EB17
-
The medicine is used in adult patients for the symptomatic treatment of stable angina pectoris (at a heart rate of 70 beats per minute or more) and for the treatment of chronic heart failure (at a heart rate of 75 beats per minute or more).
Dosage form: tablets, film-coated
Active substance Dosage ivabradine 7.5 mg ATC: C01EB17
-
The medicine is used in men to treat moderate or severe lower urinary tract symptoms related to urination and bladder emptying. This results from bladder problems and prostate enlargement (benign prostatic hyperplasia).
Dosage form: tablets, modified release
Active substance Dosage solifenacin succinate 6 mg tamsulosin hydrochloride 0.4 mg ATC: G04CA53
-
The medicine is used in adults for the treatment of Parkinson's disease. It helps to increase and maintain dopamine levels in the brain, which affects motor control.
Dosage form: tablets
Active substance Dosage rasagiline tartrate 1.44 mg ATC: N04BD02
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and relieves the symptoms of the disease.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 200 mcg ATC: B01AC27
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which lowers the pressure within them, relieves disease symptoms, and slows its progression.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 400 mcg ATC: B01AC27
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, relieves disease symptoms, and slows its progression.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 600 mcg ATC: B01AC27
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which lowers the pressure within them, relieves disease symptoms, and slows its progression.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 800 mcg ATC: B01AC27
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, relieves disease symptoms, and slows its progression.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 1000 mcg ATC: B01AC27
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and may slow the progression of the disease.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 1200 mcg ATC: B01AC27
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and relieves the symptoms of the disease.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 1400 mcg ATC: B01AC27
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and relieves the symptoms of the disease.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 1600 mcg ATC: B01AC27
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients for whom other medicines have not produced the expected effects or who cannot use them.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 200 mcg ATC: B01AC27
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It may be used alone or in combination with other medicines if the patient cannot take them.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 400 mcg ATC: B01AC27
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients. It may be used alone or in combination with other medicines if the patient is not eligible for their use.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 600 mcg ATC: B01AC27
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, relieves disease symptoms, and slows its progression.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 800 mcg ATC: B01AC27
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients for whom other medicines have not produced the expected effects or when other treatment methods cannot be used.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 1000 mcg ATC: B01AC27
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It may be used alone or in combination with other medicines if the patient is not eligible for their use.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 1200 mcg ATC: B01AC27
-
The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients. It may be used alone or in combination with other medicines if previous treatments have not been effective.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 1400 mcg ATC: B01AC27
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It may be used alone or in combination with other medicines.
Dosage form: tablets, film-coated
Active substance Dosage selexipag 1600 mcg ATC: B01AC27
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in a progressive phase and cannot be surgically removed.
Dosage form: capsules, hard
Active substance Dosage sunitinib maleate 16.71 mg ATC: L01EX01
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.
Dosage form: capsules, hard
Active substance Dosage sunitinib maleate 33.41 mg ATC: L01EX01
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive stage and cannot be surgically removed.
Dosage form: capsules, hard
Active substance Dosage sunitinib maleate 66.83 mg ATC: L01EX01
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) (in the progressive stage or when they cannot be surgically removed).
Dosage form: capsules, hard
Active substance Dosage sunitinib maleate 16.71 mg ATC: L01EX01
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Dosage form: capsules, hard
Active substance Dosage sunitinib maleate 33.41 mg ATC: L01EX01
-
The medicine is used in adults for the treatment of specific types of cancer: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Dosage form: capsules, hard
Active substance Dosage sunitinib maleate 66.83 mg ATC: L01EX01
-
It is used in men to treat moderate to severe bladder and prostate enlargement (benign prostatic hyperplasia) symptoms. It helps, among other things, with problems starting urination, a weak urine stream, frequent urination, and sudden urgency to urinate.
Dosage form: tablets, modified release
Active substance Dosage solifenacin succinate 6 mg tamsulosin hydrochloride 0.4 mg ATC: G04CA53